Deakin University
Browse

Coassembled nanostructured bioscaffold reduces the expression of proinflammatory cytokines to induce apoptosis in epithelial cancer cells

Version 2 2024-06-06, 07:29
Version 1 2016-03-21, 14:37
journal contribution
posted on 2024-06-06, 07:29 authored by R Li, S Pavuluri, K Bruggeman, BM Long, AJ Parnell, A Martel, SR Parnell, Fred PfefferFred Pfeffer, AJC Dennison, KR Nicholas, Colin BarrowColin Barrow, DR Nisbet, Richard WilliamsRichard Williams
The local inflammatory environment of the cell promotes the growth of epithelial cancers. Therefore, controlling inflammation locally using a material in a sustained, non-steroidal fashion can effectively kill malignant cells without significant damage to surrounding healthy cells. A promising class of materials for such applications are the nanostructured scaffolds formed by epitope containing minimalist self-assembled peptides (SAPs), as they are bioactive on a cellular length scale, whilst presenting as an easily handled hydrogel. Here, we show that the assembly process distributes an anti-inflammatory polysaccharide, fuccoidan, localised to the nanofibers to function as an anti-inflammatory biomaterial for cancer therapy. We show that it supports healthy cells, whilst inducing apoptosis in cancerous endothelial cells, as demonstrated by the downregulation of the proinflammatory gene and protein expression pathways associated with epithelial cancer progression. Our findings highlight an innovative material approach with potential applications as local epithelial cancer immunotherapy and drug delivery vehicles.

History

Journal

Nanomedicine: Nanotechnology, Biology, and Medicine

Volume

12

Pagination

1397-1407

Location

United States

ISSN

1549-9634

eISSN

1549-9642

Language

English

Publication classification

C Journal article, C1 Refereed article in a scholarly journal

Copyright notice

2016, Elsevier

Issue

5

Publisher

ELSEVIER